Can Bexsero (meningococcal group B vaccine) and the influenza (flu) vaccine be administered together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Bexsero and Flu Vaccine Be Given Together?

Yes, Bexsero (MenB-4C) and influenza vaccine can be safely administered together at the same visit, using separate anatomic sites. 1, 2

Evidence Supporting Simultaneous Administration

The CDC/ACIP explicitly supports simultaneous administration of inactivated vaccines, including meningococcal and influenza vaccines, as this approach produces satisfactory antibody responses without increasing adverse reactions. 2 The fundamental principle is that inactivated vaccines do not interfere with immune responses to other inactivated vaccines when administered at separate anatomical sites. 1, 2

Key Supporting Evidence:

  • Both vaccines are inactivated, eliminating concerns about vaccine interference that might occur with live vaccines. 2

  • Pneumococcal and influenza vaccines (both inactivated, like Bexsero) can be administered simultaneously at different sites without increasing side effects, establishing precedent for this practice. 1, 2, 3

  • Studies demonstrate that approximately one-third of vaccine-preventable cases could have been prevented if vaccines had been administered simultaneously rather than delayed. 2

Proper Administration Protocol

Site Selection:

  • Administer both vaccines at separate anatomic sites, preferably different limbs (e.g., one in each arm). 2

  • If using high-dose or adjuvanted influenza vaccines, inject in a different limb from Bexsero to minimize local reactions. 2

Technical Requirements:

  • Never mix vaccines in the same syringe unless specifically FDA-approved for mixing. 2

  • Prepare both vaccines for administration at the same visit. 2

  • Observe the patient for 15 minutes post-vaccination as standard practice. 2

Clinical Benefits of Same-Day Administration

Simultaneous administration is particularly important when a patient is unlikely to return for future vaccinations, as this approach increases compliance, reduces implementation costs, and eliminates missed vaccination opportunities. 2

Common Pitfalls to Avoid

  • Do not delay vaccination to administer vaccines separately when they can be given simultaneously—there is no medical justification for this delay. 2, 4

  • Do not mix vaccines in the same syringe unless specifically approved by the FDA. 2

  • Do not use the same anatomic site for multiple vaccines; always use separate injection sites. 2

Special Considerations for Bexsero

While Bexsero has been associated with more solicited systemic adverse events (particularly fever) in infants when coadministered with routine infant vaccines, the vaccine's reactogenicity profile is generally acceptable. 5 This does not contraindicate simultaneous administration with influenza vaccine, but providers should counsel patients about the possibility of increased local and systemic reactions when multiple vaccines are given together. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Simultaneous Administration of HPV, Influenza, and Pneumococcal Vaccines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vaccination Guidelines for CKD Stage 4 Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Botox and Influenza Vaccine Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Multicomponent meningococcal serogroup B vaccine (4CMenB; Bexsero(®)): a review of its use in primary and booster vaccination.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.